Medicinal cannabis for treating post-traumatic stress disorder and comorbid depression: real-world evidence.

Michael T LynskeyAlkyoni Athanasiou-FragkouliHannah ThurgurAnne Katrin SchlagDavid John Nutt

Published in: BJPsych open (2024)

Depression is common among individuals seeking CBMPs to treat PTSD and is associated with greater symptom severity and poorer quality of life. Effectiveness of CBMPs for treating PTSD does not appear to be impaired in people with comorbid depression.

Keyphrases

depressive symptoms
social support
sleep quality
randomized controlled trial
systematic review
posttraumatic stress disorder
mental health
patient reported